Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-15-001699
Filing Date
2015-04-13
Accepted
2015-04-10 18:59:43
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cbmg_10ka.htm 10-K/A 2648369
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cbmg_ex231.htm EX-23.1 3298
3 CERTIFICATION cbmg_ex311.htm EX-31.1 18661
4 CERTIFICATION cbmg_ex312.htm EX-31.2 19006
5 CERTIFICATION cbmg_ex321.htm EX-32.1 9754
12 img01.jpg GRAPHIC 55025
  Complete submission text file 0001354488-15-001699.txt   8776186

Data Files

Seq Description Document Type Size
6 cmbg-20141231.xml EX-101.INS 1031118
7 cmbg-20141231.xsd EX-101.SCH 51640
8 cmbg-20141231_cal.xml EX-101.CAL 62387
9 cmbg-20141231_def.xml EX-101.DEF 125107
10 cmbg-20141231_lab.xml EX-101.LAB 391286
11 cmbg-20141231_pre.xml EX-101.PRE 288203
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36498 | Film No.: 15765521
SIC: 2836 Biological Products, (No Diagnostic Substances)